These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6199509)

  • 41. Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.
    Yamaguchi T; Iwata K; Kobayashi M; Ogawa M; Fukushi H; Hirai K
    Arch Virol; 1996; 141(8):1493-507. PubMed ID: 8856029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cooperation of structural proteins during late events in the life cycle of polyomavirus.
    Forstová J; Krauzewicz N; Wallace S; Street AJ; Dilworth SM; Beard S; Griffin BE
    J Virol; 1993 Mar; 67(3):1405-13. PubMed ID: 8382302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoclonal antibodies against adenovirus type 5: preparation and preliminary characterization.
    Russell WC; Patel G; Precious B; Sharp I; Gardner PS
    J Gen Virol; 1981 Oct; 56(Pt 2):393-408. PubMed ID: 6171612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Location and primary structure of a major antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW
    Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique.
    Roivainen M; Närvänen A; Korkolainen M; Huhtala ML; Hovi T
    Virology; 1991 Jan; 180(1):99-107. PubMed ID: 1701949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ability of linear and cyclic peptides of neutralization antigenic site 1 of poliovirus type 1 to induce virus cross-reactive and neutralizing antibodies.
    van der Werf S; Briand JP; Plaué S; Burckard J; Girard M; Van Regenmortel MH
    Res Virol; 1994; 145(6):349-59. PubMed ID: 7535942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Structural polypeptide VP1 in poliovirus type 1 induced by neutralizing antibodies].
    Blondel B; Crainic R; Horodniceanu F
    C R Seances Acad Sci III; 1982 Jan; 294(2):91-4. PubMed ID: 6282399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.
    Bachrach HL; Moore DM; McKercher PD; Polatnick J
    J Immunol; 1975 Dec; 115(6):1636-41. PubMed ID: 171309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hit-and-run neutralization of poliovirus.
    Brioen P; Rombaut B; Boeyé A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
    Ketterlinus R; Wiegers K
    Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes.
    Lefrancois L; Lyles DS
    Virology; 1982 Aug; 121(1):168-74. PubMed ID: 6180551
    [No Abstract]   [Full Text] [Related]  

  • 52. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.
    Wiegers KJ; Wetz K; Dernick R
    J Virol; 1990 Mar; 64(3):1283-9. PubMed ID: 1689392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibodies to infectious pancreatic necrosis virus: analysis of viral epitopes and comparison of different isolates.
    Caswell-Reno P; Reno PW; Nicholson BL
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2193-205. PubMed ID: 2428927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.
    Icenogle J; Gilbert SF; Grieves J; Anderegg J; Rueckert R
    Virology; 1981 Nov; 115(1):211-5. PubMed ID: 6270899
    [No Abstract]   [Full Text] [Related]  

  • 56. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1.
    van der Werf S; Wychowski C; Bruneau P; Blondel B; Crainic R; Horodniceanu F; Girard M
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5080-4. PubMed ID: 6308670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.
    Robertson BH; Morgan DO; Moore DM
    Virus Res; 1984 Sep; 1(6):489-500. PubMed ID: 6085200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Species- and genus-specific antigenic determinants of simian agent 12 VP1 as defined with monoclonal antibodies.
    Benton CV; Gilden RV; Shah KV
    Virology; 1982 Mar; 117(2):490-5. PubMed ID: 6175092
    [No Abstract]   [Full Text] [Related]  

  • 59. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.